
### [MONDO:0019293](http://purl.obolibrary.org/obo/MONDO_0019293)
**Label:** skin vascular disease

**Subclasses:** [MONDO:0019180](http://purl.obolibrary.org/obo/MONDO_0019180) (hereditary hemorrhagic telangiectasia), [MONDO:0019557](http://purl.obolibrary.org/obo/MONDO_0019557) (Chilblain lupus), [MONDO:0007864](http://purl.obolibrary.org/obo/MONDO_0007864) (Klippel-Trenaunay syndrome), [MONDO:0011457](http://purl.obolibrary.org/obo/MONDO_0011457) (ataxia-telangiectasia-like disorder), [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), [MONDO:0012017](http://purl.obolibrary.org/obo/MONDO_0012017) (Parkes Weber syndrome), [MONDO:0019803](http://purl.obolibrary.org/obo/MONDO_0019803) (angioma serpiginosum), 

**Corr. equiv. classes:** [Orphanet:2346](http://www.orpha.net/ORDO/Orphanet_2346), [Orphanet:100](http://www.orpha.net/ORDO/Orphanet_100), [Orphanet:95429](http://www.orpha.net/ORDO/Orphanet_95429), [Orphanet:251347](http://www.orpha.net/ORDO/Orphanet_251347), [OMIM:149000](http://purl.obolibrary.org/obo/OMIM_149000), [OMIM:208900](http://purl.obolibrary.org/obo/OMIM_208900), [Orphanet:90280](http://www.orpha.net/ORDO/Orphanet_90280), [Orphanet:90307](http://www.orpha.net/ORDO/Orphanet_90307), [OMIM:608355](http://purl.obolibrary.org/obo/OMIM_608355), [Orphanet:774](http://www.orpha.net/ORDO/Orphanet_774), [OMIM:604391](http://purl.obolibrary.org/obo/OMIM_604391), 

**Class expressions from DL-Learner:**

- [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0002088](http://purl.obolibrary.org/obo/HP_0002088) (Abnormality of lung morphology) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0002088](http://purl.obolibrary.org/obo/HP_0002088) (Abnormality of lung morphology) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0002088](http://purl.obolibrary.org/obo/HP_0002088) (Abnormality of lung morphology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0002088](http://purl.obolibrary.org/obo/HP_0002088) (Abnormality of lung morphology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 63.64%


